デフォルト表紙
市場調査レポート
商品コード
1466134

臨床試験サプライ&ロジスティクス市場:サービス別、タイプ別、フェーズ別、治療領域別、エンドユーザー別- 世界予測2024-2030年

Clinical Trial Supply & Logistics Market by Services (Comparator Sourcing, Logistics & Distribution, Manufacturing), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, Therapeutic Area, End User - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 196 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.74円
臨床試験サプライ&ロジスティクス市場:サービス別、タイプ別、フェーズ別、治療領域別、エンドユーザー別- 世界予測2024-2030年
出版日: 2024年04月17日
発行: 360iResearch
ページ情報: 英文 196 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床試験サプライ&ロジスティクス市場規模は2023年に243億3,000万米ドルと推定され、2024年には262億米ドルに達し、CAGR 7.75%で2030年には410億4,000万米ドルに達すると予測されています。

臨床試験サプライ&ロジスティクスは、臨床試験の実施に必要な臨床試験材料(CTM)の計画、管理、保管、流通を包括します。これらの資材には、治験薬(IMP)、プラセボ、患者用キット、補助用品、ラベリングサービスなどが含まれます。CTSLの主な目的は、製品の品質と完全性を維持しながら、製造管理及び物流管理に関する基準(GMP)及び流通管理に関する基準(GDP)を遵守し、効率的に臨床試験を実施することです。慢性疾患の蔓延と医薬品研究開発プロセスへの政府投資の増加が、臨床試験サプライ&ロジスティクスの使用を後押ししています。その一方で、臨床試験には多大なコストがかかることや、訓練を受けた専門家の数が限られていることが、市場の成長を妨げています。しかし、医薬品開発プロジェクトへの関心の高まりと臨床試験のアウトソーシングが相まって、今後数年間はその利用が増加すると予想されます。

主な市場の統計
基準年[2023] 243億3,000万米ドル
予測年[2024] 262億米ドル
予測年 [2030] 410億4,000万米ドル
CAGR(%) 7.75%

サービス需要が高まるコールドチェーン流通サービスの継続的進歩

コンパレータの調達は臨床試験の重要な側面であり、サプライチェーンマネジメント企業は信頼できる承認された供給元から必要な医薬品やその他の材料を調達し、治験薬や参考品を調達します。このプロセスにより、異なる施設や国にまたがる治験期間中、標準的な供給が維持されます。コンパレータの調達は、製品またはその品質のばらつきによる潜在的な混乱を回避しつつ、試験結果の一貫性を維持するのに役立ちます。ロジスティクス&ディストリビューションは、さまざまな地域にまたがる複数の研究施設に対する治験薬の輸送と配送を管理します。これには、通関手続きの調整、各国の規制遵守要件の監視、必要に応じてコールドチェーン保管の確保などが含まれます。製造とは、医薬品有効成分(API)、賦形剤、医薬品、プラセボ製剤を含む臨床試験材料の製造を指します。製造工程は、高品質の製品が全試験期間を通じて一貫して製造されるよう、規制当局が定めた厳格な適正製造規範(GMP)ガイドラインを遵守しなければならないです。パッケージング、ラベリング、および盲検化サービスは、研究施設に出荷するための最終的な臨床試験材料の準備に対応します。包装では、輸送中の適切な環境条件を維持しながら、特定のプロトコール要件に従って単位用量パックまたはバルク包装を作成します。ラベリングには、投与量、保存方法、有効期限、固有の識別コードなどの正確な情報をパッケージに印刷することが含まれます。盲検化(Blinding)とは、試験結果における潜在的なバイアスを回避するため、試験参加者、治験責任医師、施設スタッフから治療割り付けを隠すプロセスを指します。保管・保存サービスは、保管施設に最初に到着してから最終的に破棄されるまでのライフサイクル全体を通して、臨床試験材料を安全に保管することを対象とし、これには適切な温度管理環境の維持、材料の取り扱いに関する規制ガイドラインの遵守、許可された担当者へのアクセス制限の徹底などが含まれます。

タイプ製薬セクターにおける低分子の利用急増

臨床試験の供給とロジスティクスにおいて、生物学的製剤、医療機器、低分子は、特定の医療ニーズと治療目的に合わせた独自の利点を提供します。生物学的製剤(バイオ医薬品)は、生体を通して開発されたもので、病気の細胞を標的にする正確な能力から好まれています。複雑な製造やコールドチェーン管理が必要であるにもかかわらず、従来の治療法では不十分であった疾患に対して、副作用を最小限に抑えた効果的な治療法を提供します。医療機器には、シンプルなツールや、非侵襲的な診断や治療の選択肢として支持されているMRI装置などの高度なシステムがあり、業界大手はロジスティック企業に支えられています。低分子医薬品は、分子量が小さく細胞への浸透が容易であることが特徴で、汎用性と投与のしやすさから極めて重要です。生物学的製剤、デバイス、低分子のいずれを選択するかは、対応する特定の健康状態、治療や研究の目標、ロジスティクスの考慮事項にかかっており、患者ケアや臨床研究を進める上で、多様かつ補完的な役割を果たすことが強調されています。

フェーズ第3相臨床試験におけるサプライ&ロジスティクスサービスの範囲の拡大

バイオアベイラビリティ試験は、有効成分または治療化合物が作用部位に浸み込み、利用可能になる速度と程度を決定します。生物学的同等性試験は、2つの医薬品間の生物学的利用能を比較します。これらの試験は、ジェネリック医薬品の開発において極めて重要です。第1相臨床試験は、新薬をヒトに投与する最初の試験であり、通常、少数の健康なボランティアを用いて実施されます。主な目的は、安全性、忍容性、薬物動態、薬力学を評価することです。第2相試験では、薬剤の有効性を試験し、引き続き安全性を評価します。試験集団には通常、研究対象の状態または疾患を有する患者が含まれます。第3相試験は、大規模な患者集団を対象とし、薬剤の有効性を確認し、副作用をモニタリングし、通常使用される治療法と比較し、薬剤を安全に使用するための情報を収集することを目的とします。フェーズ4(市販後調査)は、消費者販売が承認された後の医薬品の継続的な調査です。まれな副作用や長期的な副作用を検出し、一般的な使用における薬剤の有効性を比較することを目的としています。

治療領域:がん領域における民間および公的セクターの投資・研究活動の拡大

血液疾患の臨床試験サプライ&ロジスティクスでは、血液サンプルのようなデリケートな生物学的材料を取り扱うため、綿密な調整が不可欠です。このような試験では、正確な試験結果を得るためにサンプルの完全性を確保するために、特殊な保管とタイムリーな輸送が必要となることが多いです。心血管疾患の治験では、治験薬の厳格な管理とモニタリングが必要です。これらの疾患の有病率が高いことを考慮すると、治験は広範囲に及び、治験成分の流通を効率的に管理するためのスケーラブルなロジスティクス・ソリューションが必要となります。中枢神経系および精神障害の領域における臨床試験には、治験薬のデリケートな性質に起因する革新的なロジスティクス・ソリューションが必要です。これらには、特殊な取り扱い、流通プロトコル、厳格な規制遵守を必要とする規制物質が含まれます。皮膚科疾患を含む治験では、外用薬や経口薬など多様な剤形が必要とされることが多く、カスタマイズされたロジスティクス戦略が必要となります。様々な気候や地域にわたってこれらの製品の有効性を維持するためには、迅速かつ正確な物流が不可欠です。消化器系疾患の治験では、サプライチェーンは酵素からプロバイオティクスまで様々な治験薬の取り扱いに習熟し、様々な保管条件下での製品の安定性と完全性の維持に特別な注意を払う必要があります。耳鼻咽喉科疾患臨床試験のサプライ・ロジスティクスは、特殊な機器や薬剤の流通に重点を置き、臨床試験実施施設へのタイムリーな配送を確保します。これらの品目の有効性を維持するためには、特定の保管指示を遵守することが極めて重要です。免疫学試験の場合、生物製剤を使用することが多いため、コールドチェーン・ロジスティクスと、劣化を防ぐための高度なモニタリングが必要となります。このような臨床試験は世界の性質を持つため、輸送が複雑になり、追跡と温度管理のための堅牢なシステムが必要になります。治験薬供給ロジスティクスは、感染症、特にパンデミック(世界的大流行)状況における新たな治療法の必要性に伴い、迅速な拡張性と配布に重点を置いています。このような治療薬の安全で迅速な輸送メカニズムは、研究室と治験実施施設間で機密性の高い材料を移動させるために不可欠です。

代謝性疾患の臨床試験では、広範な治験薬の取り扱いが必要となり、多くの場合、個別のロジスティクス・ソリューションが必要となります。これらの化合物の完全性を確保するためには、輸送や保管条件の細部にまで注意を払うことが最も重要です。腎臓関連の試験では、投与量の正確性と投与タイミングが重要であるため、高度な追跡とロジスティクス計画によって薬剤や機器を正確に管理することが不可欠です。がん領域の臨床試験は最も複雑なもの一つであり、個々の患者に合わせた高度に専門的な治療が必要とされることが多いです。そのため、生きた細胞を含むデリケートなマテリアルを厳しい条件下で取り扱う、柔軟で迅速なロジスティクス・システムが必要となります。

さらに、希少疾患の臨床試験では、患者数が限られていることが多く、地理的に分散しているため、サプライチェーンに特有の課題があります。このような臨床試験特有のニーズや緊急性に対応するためには、ニーズに合わせたロジスティクス・ソリューションが不可欠です。さらに、呼吸器疾患の治験では、吸入器やネブライザーを含むさまざまな治験薬に対応する物流システムが必要であり、正確な温度管理と迅速な流通経路を確保し、送達時の製品の有効性を保証する必要があります。

エンドユーザー:製薬会社やバイオテクノロジー企業による臨床試験サプライ&ロジスティクスの使用増加

医薬品開発業務受託機関(CRO)は、臨床試験のすべての段階においてエンドツーエンドのサポートを提供するために臨床試験サプライ&ロジスティクスのサービスを利用しています。パートナーシップにより、CROは柔軟なサプライチェーンにアクセスすることができ、治験薬(IMP)、補助材料、デバイスを治験実施施設にタイムリーに届けることができます。さらに、これらのサービスは、CROが温度変化に敏感な出荷を管理された環境で管理し、世界中のデポの在庫レベルをリアルタイムで監視するのに役立ちます。医療機器メーカーは臨床試験サプライ&ロジスティクスサービスを利用して、複雑なサプライチェーン要件を効率的に管理しています。医療機器メーカーは、専門のロジスティクスプロバイダーの専門知識を活用することで、輸送中の適切な保管条件を維持し、輸出入規制を遵守し、世界な機器流通に伴うリスクを軽減することができます。製薬・バイオテクノロジー企業は、臨床試験のニーズに対して臨床試験サプライ&ロジスティクスのサービスに大きく依存しています。これらのサービスは、製造、包装、ラベリング、流通、保管、破壊を含む治験バイオ医薬品のサプライチェーン全体の管理を支援します。製薬・バイオ企業は、バイオ医薬品の壊れやすく繊細な性質のため、輸送中の製品の安定性を維持するための専門的な物流ソリューションを必要としています。さらに、これらのサービスは、需要予測ツールを活用し、ジャスト・イン・タイム(JIT)戦略を実施することで、製薬・バイオテクノロジー企業がサプライチェーンを最適化し、無駄を最小限に抑え、過剰在庫や在庫切れに関連する価格を削減するのに役立ちます。

地域別インサイト

南北アメリカ地域では、北米が臨床試験サプライ&ロジスティクスをかなり活用しており、米国は堅調な製薬業界と研究開発(R&D)への大規模な投資で成長をリードしています。さらに、臨床試験を実施する多数の大手製薬企業や、研究開発活動に対する政府の強力な支援が市場拡大を後押ししています。南米もヘルスケアインフラが発展し、臨床研究への注目が高まっていることから、臨床試験サプライ&ロジスティクスの使用量増加に寄与しています。アジア太平洋地域の臨床試験サプライ&ロジスティクス市場は、中国、インド、韓国、台湾、インドネシア、ベトナムなどの製薬業界が急速に発展していることから急成長しています。さらに、多くの多国籍製薬企業が、競争力のある価格でリソースを入手できることから、この地域に研究開発センターを設立したり、現地のパートナーと提携したりしています。EMEA(欧州・中東・アフリカ)地域の中でも、欧州は数多くの製薬会社やバイオテクノロジー企業が存在するため、伝統的に世界の臨床試験サプライ&ロジスティクス市場の牙城と見なされてきました。欧州連合(EU)には、治験薬(IMP)の安全性、有効性、品質を保証するために、加盟国全体で臨床試験を実施するための確立された枠組みがあります。さらに、中東・アフリカはEMEA地域の中でも新興国市場です。これは、各国政府による医療支出の増加、多国籍製薬企業による治験薬・医療機器の試験対象患者拡大のための市場開拓、継続的なヘルスケアインフラの整備、教育投資による熟練労働力の確保などが背景にあります。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは臨床試験サプライ&ロジスティクス市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析は、臨床試験サプライ&ロジスティクス市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度:有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報:市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション:将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています:

1.臨床試験サプライ&ロジスティクス市場の市場規模および予測は?

2.臨床試験サプライ&ロジスティクス市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か?

3.臨床試験サプライ&ロジスティクス市場の技術動向と規制枠組みは?

4.臨床試験サプライ&ロジスティクス市場における主要ベンダーの市場シェアは?

5.臨床試験サプライ&ロジスティクス市場への参入に適した形態や戦略的手段は?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 慢性疾患の発生率が上昇する中、経済全体で医薬品研究開発活動を強化するための政府資金が増加
      • 臨床試験の世界化と規制の調和
    • 抑制要因
      • テクノロジーの統合とデータ管理に関連する問題
    • 機会
      • サプライチェーン最適化における予測分析のための人工知能と機械学習の統合
      • 製薬メーカーとCDMOの提携活動の増加
    • 課題
      • 臨床試験の供給と物流における業務に関連する懸念
  • 市場セグメンテーション分析
    • サービス:需要の高まりとともにコールドチェーン配送サービスが継続的に進歩
    • タイプ:医薬品分野における低分子の利用の急増
    • フェーズ:フェーズ3臨床試験における供給および物流サービスの範囲の拡大
    • 治療領域:腫瘍学における民間および公共部門の投資と調査活動の急増
    • エンドユーザー:製薬会社およびバイオテクノロジー企業による臨床試験サプライ&ロジスティクスの使用増加
  • 市場動向分析
    • 強力な医薬品生産能力と南北南北アメリカのサプライチェーンにおける先進技術の統合
    • 拡大するヘルスケア分野と政府の支援策により、アジア太平洋地域全体で臨床試験のロジスティクスが強化される
    • 市場プレーヤーの強力な存在と、EMEA地域全体の医薬品サプライチェーンの発展への継続的な注力
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制枠組みの分析
  • 顧客のカスタマイズ
    • Catalent, Inc.:臨床試験の供給と物流における革新的なソリューションとサービスを促進するために、ウェビナーや会議に積極的に参加しています。
    • Infosys Limited:高精度と高品質を確保しながら低価格でソリューションを提供する浸透価格戦略に注力
    • アルマックグループ:臨床医薬品製品の保管と流通を促進するために、マーケン社が新しいマーケティングキャンペーンを開始
    • ユーロフィンサイエンティフィックグループ:ユーロフィンサイエンティフィックグループは、効果的な製品マーケティングのために会議や展示会に重点を置いています。
    • ロンザグループAG:ロンザグループAGによる世界展開の強化に向けた重要なデジタルマーケティング戦略
    • 生物学的医薬品:デジタル技術を活用してサプライチェーンを合理化し、透明性を高め、利害関係者とのコミュニケーションを改善する
    • 医療機器:利害関係者の悩みを解決する教育コンテンツの普及
    • 低分子:熾烈な競合と規制の複雑さに対処する必要性
    • 臨床試験サプライ&ロジスティクスサービスにおける多様なマーケティング戦略の採用

第6章 臨床試験サプライ&ロジスティクス市場:サービス別

  • 比較ソーシング
  • 物流・流通
  • 製造業
  • 包装、ラベル付け、ブラインド
  • 保管と保持

第7章 臨床試験サプライ&ロジスティクス市場:タイプ別

  • 生物学的製剤
  • 医療機器
  • 小分子

第8章 臨床試験サプライ&ロジスティクス市場フェーズ別

  • BA/BE研究
  • フェーズ1
  • フェーズ2
  • フェーズ3
  • フェーズ4

第9章 臨床試験サプライ&ロジスティクス市場治療領域別

  • 血液疾患
  • 心血管疾患
  • 中枢神経系と精神障害
  • 皮膚疾患
  • 消化器疾患
  • 耳鼻咽喉科疾患
  • 免疫学
  • 感染症
  • 代謝障害
  • 腎臓学
  • 腫瘍学
  • 希少疾患
  • 呼吸器疾患

第10章 臨床試験サプライ&ロジスティクス市場:エンドユーザー別

  • 契約調査機関
  • 医療機器企業
  • 製薬・バイオテクノロジー企業

第11章 南北アメリカの臨床試験サプライ&ロジスティクス市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第12章 アジア太平洋地域の臨床試験サプライ&ロジスティクス市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第13章 欧州・中東・アフリカの臨床試験サプライ&ロジスティクス市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第14章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス、2023
  • 競合シナリオ分析
    • PCMトライアルズ、オランダの臨床試験サービスを買収
    • ピラマルファーマソリューションズ、スコットランドのグランジマウスにおけるADC製造拡張の開設を祝う
    • バイオケア、世界成長戦略の一環として米国での拡大を発表
    • VaxcyteとLonzaがPCVの新たな商業製造契約を締結
    • ピラマル・ファーマ・ソリューションズ、アーメダバードのディスカバリー・サービス拠点でインビトロ生物学機能を開始
    • シグナントヘルス、新興バイオ医薬品企業の臨床開発を加速・効率化するシグナントバイオテックを設立
    • N-SIDE、世界規模の臨床試験サプライ管理の未来を形作る革新的なソフトウェア、Lighthouseを発表
    • ズエリッグ・ファーマとGSKがシンガポールにワクチン流通拠点を設立
    • アリセウム・セラピューティクスとユーロフィンCDMOが医薬品マルチプロジェクト契約を締結
    • Vial、Royale International Groupとの戦略的提携を発表
    • BiocairがTrakCelと提携し、サプライチェーンの可視性を向上
    • IDEAYA、ファイザーとの臨床試験協力および供給契約を拡大
    • キャタレント、ドイツの臨床供給施設で2,000万米ドル規模の拡張工事を開始
    • ユーロフィンバイオファーマ製品試験ENCOが米国での能力を拡大
    • Calyxが新たな臨床試験供給予測サービスを導入
    • キャタレント、温度管理能力向上のためシンガポール臨床供給施設の拡張を完了
    • パレクセル、中国蘇州に臨床試験用品および物流倉庫を開設

第15章 競合ポートフォリオ

  • 主要企業プロファイル
  • 主要製品ポートフォリオ
図表

LIST OF FIGURES

  • FIGURE 1. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET DYNAMICS
  • FIGURE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COMPARATOR SOURCING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COMPARATOR SOURCING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COLD CHAIN DISTRIBUTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COLD CHAIN DISTRIBUTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NON-COLD CHAIN DISTRIBUTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NON-COLD CHAIN DISTRIBUTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MANUFACTURING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PACKAGING, LABELING, & BLINDING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PACKAGING, LABELING, & BLINDING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STORAGE & RETENTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STORAGE & RETENTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BA/ BE STUDIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BA/ BE STUDIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 1, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 1, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 2, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 2, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 3, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 3, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 4, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 4, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CNS & MENTAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CNS & MENTAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ENT DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ENT DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NEPHROLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RARE DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 72. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 73. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 74. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 75. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 76. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 77. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 78. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 79. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 80. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 81. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 82. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 83. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 84. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 85. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 88. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 89. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 90. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 91. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 92. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 93. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 94. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 95. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 96. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 97. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 98. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 99. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 102. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 103. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 104. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 105. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 106. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 107. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 108. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 109. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 110. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 111. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 114. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 115. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 116. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 117. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 118. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 119. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 120. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 121. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 122. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 123. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 126. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 127. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 128. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 129. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 130. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 131. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 132. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 133. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 134. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 135. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 138. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 139. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 140. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 141. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 142. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 143. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 144. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 145. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 146. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 147. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 150. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 151. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 152. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 153. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 154. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 155. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 156. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 171. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 172. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 173. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 174. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 175. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 178. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 179. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 180. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 181. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 182. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 183. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 184. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 185. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 186. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 187. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 190. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 191. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 192. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 193. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 194. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 195. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 196. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 197. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 198. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 199. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 200. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 201. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 202. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 203. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 204. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 205. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 206. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 207. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 208. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 209. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 210. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 211. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 214. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 215. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 216. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 217. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 218. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 219. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 220. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 221. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 222. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 223. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 224. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 225. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 226. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 227. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 228. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 229. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 230. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 231. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 232. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 233. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 234. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 235. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 238. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 239. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 240. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 241. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 242. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 243. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 244. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 245. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 246. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 247. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 250. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 251. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 252. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 253. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 254. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 255. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 256. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 257. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 258. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 259. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 262. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 263. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 264. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 265. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 266. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 267. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 268. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 269. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 270. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 271. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 272. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 273. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 274. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 275. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 276. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 277. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 278. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 279. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 280. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 281. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 282. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 283. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 286. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 287. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 288. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 289. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 290. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 291. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 292. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 293. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 294. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 295. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 296. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 297. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 298. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 299. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 300. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAP
目次
Product Code: MRR-501246436315

[196 Pages Report] The Clinical Trial Supply & Logistics Market size was estimated at USD 24.33 billion in 2023 and expected to reach USD 26.20 billion in 2024, at a CAGR 7.75% to reach USD 41.04 billion by 2030.

Clinical trial supply & logistics encompasses the planning, management, storage, and distribution of clinical trial materials (CTMs) needed to conduct clinical studies. These materials include investigational medicinal products (IMPs), placebos, patient kits, ancillary supplies, and labeling services. The main objective of CTSL is to ensure that clinical trials are conducted efficiently and in compliance with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) guidelines while maintaining product quality and integrity. The prevalence of chronic disorders and increasing government investments in pharmaceutical research & development process drives the use of clinical trial supply & logistics. On the contrary, the cost-intensive nature of clinical trials and the limited availability of trained professionals hinders market growth. However, growing interest in drug development projects coupled with outsourcing clinical trials is expected to increase its usage in the coming years.

KEY MARKET STATISTICS
Base Year [2023] USD 24.33 billion
Estimated Year [2024] USD 26.20 billion
Forecast Year [2030] USD 41.04 billion
CAGR (%) 7.75%

Services: Continuous advancements in cold chain distribution services with growing demand

Comparator sourcing is a crucial aspect of clinical trials where supply chain management companies source the required drugs and other materials from reliable and approved sources, which involves procuring investigational and reference products. The process ensures that standardized supplies are maintained throughout the trial period across different sites and countries. Comparator sourcing helps maintain consistency in trial results while avoiding any potential disruptions due to variations in products or their quality. Logistics & distribution encompasses the management of transportation and delivery of clinical trial materials to multiple research sites across various regions. This includes coordinating with customs clearance procedures, monitoring regulatory compliance requirements for each country, and ensuring cold chain storage is maintained if necessary. Manufacturing refers to the production of clinical trial materials, including active pharmaceutical ingredients (APIs), excipients, drug products, and placebo formulations. Manufacturing processes must adhere to strict Good Manufacturing Practices (GMP) guidelines set by regulatory authorities to ensure high-quality products are produced consistently throughout the entire study period. Packaging, labeling, and blinding services deal with preparing the final clinical trial materials for shipment to research sites. Packaging involves creating unit dose packs or bulk packaging according to specific protocol requirements while maintaining appropriate environmental conditions during transport. Labeling includes printing accurate information on packages, such as dosage strength, storage instructions, expiry date(s), and unique identification codes. Blinding refers to the process of concealing treatment allocations from trial participants, investigators, and site staff to avoid any potential biases in the results. Storage & retention services cover the secure housing of clinical trial materials throughout their entire lifecycle, from initial arrival at storage facilities until final destruction, including maintaining appropriate temperature-controlled environments, adhering to regulatory guidelines on material handling, and ensuring that limited access is granted to authorized personnel.

Type: Surging utilization of small molecules in the pharmaceutical sector

In clinical trial supplies & logistics, biological drugs, medical devices, and small molecules present unique advantages tailored to specific medical needs and treatment objectives. Biologic drugs, or biopharmaceuticals, developed through living organisms, are preferred for their precise ability to target diseased cells. They offer effective treatments with minimal side effects for conditions where traditional therapies fall short despite their need for complex manufacturing and cold chain management. Medical devices include simple tools, advanced systems, such as MRI machines, favored for their non-invasive diagnostics and treatment options, with industry giants supported by logistic companies. Small molecules, characterized by their low molecular weight and ease of penetration into cells, are pivotal for their versatility and ease of administration. The selection among biologics, devices, or small molecules hinges on the specific health condition being addressed, the goals of treatment or research, and logistical considerations, highlighting the diverse and complementary roles they play in advancing patient care and clinical research.

Phase: Increasing scope of supply & logistics services in phase 3 clinical trials

Bioavailability studies determine the rate and extent to which the active ingredient or therapeutic compound is soaked and becomes available at the site of action. Bioequivalence studies compare the bioavailability between two pharmaceutical products. These studies are crucial in the development of generic drugs. Phase 1 trials are the initial infusion of a new drug into humans, typically conducted with a few healthy volunteers. The primary goal is to assess safety, tolerability, pharmacokinetics, and pharmacodynamics. Phase 2 trials test the efficacy of a drug and continue to evaluate its safety. The study population typically includes patients with the condition or disease being studied. Phase 3 trials involve large groups of patients and aim to confirm a drug's efficacy, monitor side effects, compare it to typically used treatments, and gather information that allows the drug to be used safely. Phase 4, or post-marketing surveillance, involves the ongoing study of a drug after it has been approved for consumer sale. It aims to detect rare or long-term adverse effects and compare the drug's effectiveness in general use.

Therapeutic Area: Proliferating private and public sector investments and research activities in oncology

In clinical trial supply & logistics for blood disorders, meticulous coordination is essential to handle sensitive biological materials, such as blood samples. These trials often require specialized storage and timely transportation to ensure sample integrity for accurate trial outcomes. Supply chain management for cardiovascular disease trials necessitates rigorous control and monitoring of investigational medicinal products. Trials are extensive and require scalable logistics solutions to manage trial component distribution efficiently, considering the high prevalence of these diseases. Clinical trials in the CNS and mental disorder domain necessitate innovative logistic solutions owing to the sensitive nature of investigational drugs. These include controlled substances requiring specialized handling, distribution protocols, and stringent regulatory compliance. Trials involving dermatological disorders often necessitate diverse product forms, including topicals and orals, requiring customized logistics strategies. Quick and precise distribution is vital to maintain the efficacy of these products across various climates and regions. For digestive disorder trials, the supply chain should be adept at handling various investigational products, from enzymes to probiotics, with special attention to maintaining product stability and integrity under different storage conditions. Supply logistics for ENT disease trials focus on the distribution of specialized devices and medication, ensuring timely delivery to trial sites. It's crucial to adhere to specific storage instructions to preserve the effectiveness of these items. Immunology trials often involve biologics that require cold chain logistics and advanced monitoring to guard against degradation. The global nature of these trials adds complexity to shipping and requires robust systems for tracking and temperature management. Trial supply logistics are focused on rapid scalability and distribution with the need for new treatments in infectious diseases, especially in pandemic situations. Secure and quick transport mechanisms for such therapeutics are critical for moving sensitive materials between labs and trial sites.

Clinical trials for metabolic disorders require handling a broad spectrum of investigational products, often necessitating personalized logistics solutions. Attention to detail in shipping and storage conditions is paramount to ensure the integrity of these compounds. Given the importance of dose accuracy and timing in nephrology-related trials, ensuring the precise management of medications and devices with advanced tracking and logistical planning is essential. Oncology trials are among the most complex, requiring highly specialized treatments often tailored to individual patients. This necessitates a flexible and responsive logistics system that handles sensitive materials, including live cells, under strict conditions.

Moreover, clinical trials for rare diseases present unique supply chain challenges due to the often-limited patient population and scattered geographical distribution. Tailored logistics solutions are essential to address these trials' specific needs and urgency. Furthermore, in trials for respiratory disorders, logistical systems must accommodate a range of investigational products, including inhalers and nebulizers, requiring precise temperature control and swift distribution channels to ensure product efficacy upon delivery.

End User: Rising use of clinical trial supply & logistics by pharmaceutical & biotechnology companies

Contract research organizations (CROs) rely on clinical trial supply & logistics services to provide end-to-end support throughout all stages of clinical trials. Through partnerships, CROs can access flexible supply chains, ensuring timely delivery of investigational medicinal products (IMP), ancillary materials, and devices to trial sites. Moreover, these services help CROs manage temperature-sensitive shipments through controlled environments and monitor real-time inventory levels at depots worldwide. Medical device companies utilize clinical trial supply & logistics services to manage their complex supply chain requirements efficiently. Medical device companies can maintain proper storage conditions during transportation, adhere to import/export regulations, and reduce risks associated with global device distribution by leveraging specialized logistics providers' expertise. Pharmaceutical & biotechnology companies heavily depend on clinical trial supply & logistics services for their clinical trial needs, and these services assist in managing the entire supply chain of investigational biopharmaceutical products, including manufacturing, packaging, labeling, distribution, storage, and destruction. Pharmaceutical & biotechnology companies require specialized logistics solutions to maintain product stability during transportation owing to biopharmaceutical products' fragile and sensitive nature. Furthermore, these services help pharmaceutical & biotechnology companies optimize their supply chains by utilizing demand forecasting tools and implementing just-in-time (JIT) strategies to minimize wastage and reduce prices associated with overstocking or stockouts.

Regional Insights

In the Americas region, North America has considerable utilization of clinical trial supply & logistics, with the United States leading the growth with its robust pharmaceutical industry and extensive investment in research and development (R&D). Furthermore, numerous leading pharmaceutical companies conducting clinical trials and strong government support for R&D activities drive market expansion. South America also contributes to increasing clinical trial supply & logistics usage due to its developing healthcare infrastructure and growing focus on clinical research. The Asia-Pacific region's clinical trial supply & logistics market is growing rapidly due to its rapidly evolving pharmaceutical industry in China, India, South Korea, Taiwan, Indonesia, and Vietnam, among others. Moreover, many multinational pharmaceutical companies have established their R&D centers or collaborations with local partners in this region due to resource availability at competitive prices. Within the EMEA region, Europe has been traditionally considered a stronghold for the global clinical trial supply & logistics market due to the presence of numerous pharmaceutical and biotechnology companies. The European Union (EU) has a well-established framework for conducting clinical trials across its member states that ensures the safety, efficacy, and quality of investigational medicinal products (IMPs). In addition, Middle East & Africa are emerging markets within the EMEA region due to increasing healthcare expenditure by governments, expansion of multinational pharmaceutical companies into these markets to tap a larger patient pool for testing their investigational drugs/devices, continuous development of healthcare infrastructure and availability of skilled workforce due to their investments in education.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Clinical Trial Supply & Logistics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Trial Supply & Logistics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Supply & Logistics Market, highlighting leading vendors and their innovative profiles. These include Acnos Pharma GmbH, ADAllen Pharma Ltd, Almac Group Limited, Ancillare, LP, Avantor, Inc., Beroe Holdings Inc., Biocair International Limited, Calyx, Catalent, Inc., Clinical Services International LTD, Clinigen Group PLC, COREX LOGISTICS LIMITED, DHL Group, Eurofins Scientific SE, Experic, LLC, FedEx Corporation, ICON PLC, Inceptua S.A., Infosys Limited, IPS Pharma, KLIFO A/S, Lonza Group AG, Marken Limited by United Parcel Service, Inc., Microsoft Corporation, Myonex, Inc., N-SIDE SA, NUVISAN GmbH, OCT Clinical GmbH, Octalsoft, Parexel International Corporation, PCI Pharma Services, PHOENIX Pharmahandel GmbH & Co KG, Piramal Pharma Limited, Recipharm AB, SAP SE, Sharp Services, LLC, Signant Health, SIRO Clinpharm Private Limited, Thermo Fisher Scientific Inc., Tower Cold Chain Solutions, Uniphar PLC, Walden Group, and Zuellig Pharma Pte Ltd by Interpharma Investments Limited.

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Supply & Logistics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Services
    • Comparator Sourcing
    • Logistics & Distribution
      • Cold Chain Distribution
      • Non-Cold Chain Distribution
    • Manufacturing
    • Packaging, Labeling, & Blinding
    • Storage & Retention
  • Type
    • Biologic Drugs
    • Medical Devices
    • Small Molecules
  • Phase
    • BA/ BE studies
    • Phase 1
    • Phase 2
    • Phase 3
    • Phase 4
  • Therapeutic Area
    • Blood Disorders
    • Cardiovascular Diseases
    • CNS & Mental Disorders
    • Dermatological Disorders
    • Digestive Disorders
    • ENT Diseases
    • Immunology
    • Infectious Diseases
    • Metabolic Disorders
    • Nephrology
    • Oncology
    • Rare Diseases
    • Respiratory Disorders
  • End User
    • Contract Research Organisations
    • Medical Devices Companies
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • Massachusetts
        • Minnesota
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Clinical Trial Supply & Logistics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Trial Supply & Logistics Market?

3. What are the technology trends and regulatory frameworks in the Clinical Trial Supply & Logistics Market?

4. What is the market share of the leading vendors in the Clinical Trial Supply & Logistics Market?

5. Which modes and strategic moves are suitable for entering the Clinical Trial Supply & Logistics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising government funds to strengthen pharmaceutical R&D activities across economies with increasing incidence of chronic diseases
      • 5.1.1.2. Globalization of clinical trials and harmonization of regulations
    • 5.1.2. Restraints
      • 5.1.2.1. Problems associated with technology integration and data management
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of artificial intelligence and machine learning for predictive analytics in supply chain optimization
      • 5.1.3.2. Increasing partnership activities between pharmaceutical manufacturers and CDMOs
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with the operations within clinical trial supply and logistics
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Services: Continuous advancements in cold chain distribution services with growing demand
    • 5.2.2. Type: Surging utilization of small molecules in the pharmaceutical sector
    • 5.2.3. Phase: Increasing scope of supply & logistics services in phase 3 clinical trials
    • 5.2.4. Therapeutic Area: Proliferating private and public sector investments and research activities in oncology
    • 5.2.5. End User: Rising use of clinical trial supply & logistics by pharmaceutical & biotechnology companies
  • 5.3. Market Trend Analysis
    • 5.3.1. Strong pharmaceutical production capability and integration of advanced technologies in the supply chain across the Americas
    • 5.3.2. Expanding healthcare sectors coupled with supportive government initiatives augmenting clinical trial logistics across APAC region
    • 5.3.3. Robust presence of market players and continuous focus on advancing pharmaceutical supply chain across EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis
  • 5.8. Client Customization
    • 5.8.1. Catalent, Inc. : Active participation in webinars and conferences to promote innovative solutions and services in clinical trial supply and logistics
    • 5.8.2. Infosys Limited: Focus on penetration pricing strategy to provide solution at a low price while ensuring high precision and quality
    • 5.8.3. Almac Group: Launch of new marketing campaign by Marken Limited to promote clinical drug product storage and distribution
    • 5.8.4. Eurofins Scientific Group: Eurofins Scientific Group's focus on conferences and fairs for effective product marketing
    • 5.8.5. Lonza Group AG: Significant digital marketing strategies by Lonza Group AG to enhance their global reach
    • 5.8.6. Biologic Drugs: Utilisation of digital technologies to streamline the supply chain, enhance transparency, and improve communication with stakeholders
    • 5.8.7. Medical Devices: Disseminating educational content addressing stakeholders' pain points
    • 5.8.8. Small Molecules: Need to address intense competition and regulatory complexities
    • 5.8.9. Adoption of diverse marketing strategies for clinical trial supply & logistics services

6. Clinical Trial Supply & Logistics Market, by Services

  • 6.1. Introduction
  • 6.2. Comparator Sourcing
  • 6.3. Logistics & Distribution
  • 6.4. Manufacturing
  • 6.5. Packaging, Labeling, & Blinding
  • 6.6. Storage & Retention

7. Clinical Trial Supply & Logistics Market, by Type

  • 7.1. Introduction
  • 7.2. Biologic Drugs
  • 7.3. Medical Devices
  • 7.4. Small Molecules

8. Clinical Trial Supply & Logistics Market, by Phase

  • 8.1. Introduction
  • 8.2. BA/ BE studies
  • 8.3. Phase 1
  • 8.4. Phase 2
  • 8.5. Phase 3
  • 8.6. Phase 4

9. Clinical Trial Supply & Logistics Market, by Therapeutic Area

  • 9.1. Introduction
  • 9.2. Blood Disorders
  • 9.3. Cardiovascular Diseases
  • 9.4. CNS & Mental Disorders
  • 9.5. Dermatological Disorders
  • 9.6. Digestive Disorders
  • 9.7. ENT Diseases
  • 9.8. Immunology
  • 9.9. Infectious Diseases
  • 9.10. Metabolic Disorders
  • 9.11. Nephrology
  • 9.12. Oncology
  • 9.13. Rare Diseases
  • 9.14. Respiratory Disorders

10. Clinical Trial Supply & Logistics Market, by End User

  • 10.1. Introduction
  • 10.2. Contract Research Organisations
  • 10.3. Medical Devices Companies
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Americas Clinical Trial Supply & Logistics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Clinical Trial Supply & Logistics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Clinical Trial Supply & Logistics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. PCM Trials acquires Netherlands-based Clinical Trial Service
    • 14.3.2. Piramal Pharma Solutions Commemorates Opening of its ADC Manufacturing Expansion in Grangemouth, Scotland
    • 14.3.3. Biocair Announces the U.S. Expansion as Part Of Global Growth Strategy
    • 14.3.4. Vaxcyte and Lonza Sign New Commercial Manufacturing Agreement for PCVs
    • 14.3.5. Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site
    • 14.3.6. Signant Health Launches Signant Biotech to Accelerate and Streamline Clinical Development for Emerging Biopharmaceutical Organizations
    • 14.3.7. N-SIDE Introduces Lighthouse, Innovative Software to Shape the Future of Worldwide Clinical Trial Supply Management
    • 14.3.8. Zuellig Pharma and GSK establish vaccine distribution hub in Singapore
    • 14.3.9. Ariceum Therapeutics and Eurofins CDMO Sign a Pharmaceutical Multi-Project Agreement
    • 14.3.10. Vial Announces Strategic Partnership with Royale International Group
    • 14.3.11. Biocair Partners with TrakCel to Improve Visibility in the Supply Chain
    • 14.3.12. IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer
    • 14.3.13. Catalent Starts Construction of USD 20M Expansion at Clinical Supply Facility in Germany
    • 14.3.14. Eurofins BioPharma Product Testing ENCO Expands the U.S. Capabilities Footprint
    • 14.3.15. Calyx Introduces New Clinical Trial Supply Forecasting Service
    • 14.3.16. Catalent Completes Expansion of Singapore Clinical Supply Facility for Increased Temperature-Controlled Capabilities
    • 14.3.17. Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou, China

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio